blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1354032

EP1354032 - GENE REGULATION THERAPY INVOLVING FERRITIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.06.2007
Database last updated on 09.07.2024
Most recent event   Tooltip12.12.2008Lapse of the patent in a contracting state
New state(s): CY		published on 14.01.2009  [2009/03]
Applicant(s)For all designated states
Broyles, Robert H.
212 North West 20th Street
Oklahoma City, OK 73103 / US
For all designated states
Floyd, Robert A.
6201 Harden Drive
Oklahoma City, OK 73118 / US
[2006/31]
Former [2005/51]For all designated states
Oklahoma Medical Research Foundation
825 N.E. 13th Street
Oklahoma City Oklahoma 73104 / US
Former [2003/43]For all designated states
Oklahoma Medical Research Foundation
825 N.E. 13th Street
Oklahoma City Oklahoma 73104 / US
For all designated states
THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA
University of Oklahoma, 1000 Asp Avenue
Norman, Oklahoma 73109 / US
Inventor(s)01 / see applicant
...
 [2006/31]
Former [2003/43]01 / BROYLES, Robert, H.
212 North West 20th Street
Oklahoma City, Oklahoma 73103 / US
02 / FLOYD, Robert, A.
6201 Harden Drive
Oklahoma City, OK 73118 / US
Representative(s)Dehmel, Albrecht, et al
Dehmel & Bettenhausen
Patentanwälte PartmbB
Herzogspitalstraße 11
80331 München / DE
[N/P]
Former [2004/32]Dehmel, Albrecht, Dr., et al
Dehmel & Bettenhausen Patentanwälte, Herzogspitalstrasse 11
80331 München / DE
Former [2003/43]Strych, Werner Maximilian Josef, Dr., et al
Hansmann & Vogeser, Patent- und Rechtsanwälte, Albert-Rosshaupter-Strasse 65
81369 München / DE
Application number, filing date01992721.901.11.2001
[2003/43]
WO2001US44847
Priority number, dateUS20000245003P01.11.2000         Original published format: US 245003 P
[2003/43]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0236634
Date:10.05.2002
Language:EN
[2002/19]
Type: A2 Application without search report 
No.:EP1354032
Date:22.10.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 10.05.2002 takes the place of the publication of the European patent application.
[2003/43]
Type: B1 Patent specification 
No.:EP1354032
Date:09.08.2006
Language:EN
[2006/32]
Search report(s)International search report - published on:EP24.07.2003
ClassificationIPC:C12N9/02, C07K14/47, A61K48/00, A61K38/44
[2003/43]
CPC:
A61K38/1709 (EP,US); A61P25/00 (EP); A61P25/16 (EP);
A61P25/28 (EP); A61P43/00 (EP); A61P7/06 (EP);
C07K14/47 (EP,US); A61K48/00 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/43]
Extension statesAL14.05.2003
LT14.05.2003
LV14.05.2003
MK14.05.2003
RO14.05.2003
SI14.05.2003
TitleGerman:GENREGULATIONSTHERAPIE MIT FERRITIN[2003/43]
English:GENE REGULATION THERAPY INVOLVING FERRITIN[2003/43]
French:THERAPIE DE REGULATION GENIQUE COMPRENANT LA FERRITINE[2003/43]
Entry into regional phase14.05.2003National basic fee paid 
14.05.2003Designation fee(s) paid 
14.05.2003Examination fee paid 
Examination procedure08.05.2002Request for preliminary examination filed
International Preliminary Examining Authority: US
14.05.2003Amendment by applicant (claims and/or description)
14.05.2003Examination requested  [2003/43]
04.02.2004Despatch of a communication from the examining division (Time limit: M06)
04.08.2004Reply to a communication from the examining division
17.12.2004Despatch of a communication from the examining division (Time limit: M04)
27.04.2005Reply to a communication from the examining division
30.06.2005Despatch of a communication from the examining division (Time limit: M04)
24.08.2005Reply to a communication from the examining division
30.09.2005Despatch of a communication from the examining division (Time limit: M03)
19.10.2005Reply to a communication from the examining division
22.11.2005Despatch of a communication from the examining division (Time limit: M02)
30.12.2005Reply to a communication from the examining division
20.02.2006Communication of intention to grant the patent
21.06.2006Fee for grant paid
21.06.2006Fee for publishing/printing paid
Divisional application(s)EP06015615.5  / EP1724339
Opposition(s)10.05.2007No opposition filed within time limit [2007/29]
Fees paidRenewal fee
12.11.2003Renewal fee patent year 03
12.11.2004Renewal fee patent year 04
14.11.2005Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT09.08.2006
BE09.08.2006
CH09.08.2006
CY09.08.2006
FI09.08.2006
LI09.08.2006
NL09.08.2006
IE01.11.2006
DK09.11.2006
SE09.11.2006
MC30.11.2006
[2009/03]
Former [2007/50]AT09.08.2006
BE09.08.2006
CH09.08.2006
FI09.08.2006
LI09.08.2006
NL09.08.2006
IE01.11.2006
DK09.11.2006
SE09.11.2006
MC30.11.2006
Former [2007/48]AT09.08.2006
BE09.08.2006
CH09.08.2006
FI09.08.2006
IT09.08.2006
LI09.08.2006
NL09.08.2006
IE01.11.2006
DK09.11.2006
SE09.11.2006
MC30.11.2006
Former [2007/37]AT09.08.2006
BE09.08.2006
CH09.08.2006
FI09.08.2006
IT09.08.2006
LI09.08.2006
NL09.08.2006
DK09.11.2006
SE09.11.2006
MC30.11.2006
Former [2007/28]AT09.08.2006
BE09.08.2006
CH09.08.2006
FI09.08.2006
LI09.08.2006
NL09.08.2006
DK09.11.2006
SE09.11.2006
Former [2007/23]AT09.08.2006
CH09.08.2006
FI09.08.2006
LI09.08.2006
NL09.08.2006
DK09.11.2006
SE09.11.2006
Former [2007/22]CH09.08.2006
FI09.08.2006
LI09.08.2006
NL09.08.2006
DK09.11.2006
SE09.11.2006
Former [2007/19]CH09.08.2006
FI09.08.2006
LI09.08.2006
NL09.08.2006
SE09.11.2006
Former [2007/10]CH09.08.2006
FI09.08.2006
LI09.08.2006
SE09.11.2006
Cited inInternational search[Y]  - BROYLES R H ET AL, "A ferritin-like protein binds a highly conserved CAGTGC motif in the human adult beta globin gene promoter and can mediate DNA looping in vitro.", FASEB JOURNAL, Annual Meeting of the American Society for Biochemistry and Molecular Biology;San Francisco, California, USA; May 21-25, 1995, (1995), vol. 9, no. 6, ISSN 0892-6638, page A1328, XP002218768 [Y] 1,5,11,19 * the whole document *
 [Y]  - CHASE M. ET AL., "Binding of HMG-I(Y) elicits structural changes in a silencer of the human Beta-Globin gene", AMERICAN JOURNAL OF HEMATOLOGY, WILEY-LISS, INC, (1999), vol. 60, pages 27 - 35, XP008009648 [Y] 1,5,11,19 * abstract and introduction *

DOI:   http://dx.doi.org/10.1002/(SICI)1096-8652(199901)60:1<27::AID-AJH6>3.0.CO;2-0
 [AD]  - WU Y J ET AL, "Activation of globin gene expression by cDNAs from induced K562 cells. Evidence for involvement of ferritin in globin gene expression.", THE JOURNAL OF BIOLOGICAL CHEMISTRY. UNITED STATES 15 SEP 1991, (19910915), vol. 266, no. 26, ISSN 0021-9258, pages 17566 - 17572, XP002218769 [AD] 1,5,11,19 * the whole document *
 [AD]  - HARRISON P. AND AROSIO P., "The ferritins: Molecular properties, iron storage function and cellular regulation", BIOCHIMICA ET BIOPHYSICA ACTA, ELSEVIER SCIENCE B.V., (1996), vol. 1275, pages 161 - 203, XP002218770 [AD] 1-23 * the whole document *

DOI:   http://dx.doi.org/10.1016/0005-2728(96)00022-9
 [AD]  - POUNTNEY D. ET AL., "The identification of ferritin in the nucleus of K562 cells, and investigation of a possible role in the transcriptional regulation of adult Beta-globin gene expression", JOURNAL OF CELL SCIENCE, (1999), vol. 112, pages 825 - 831, XP002218771 [AD] 1,5,11,19 * the whole document *
 [PX]  - BROYLES R H ET AL, "Specific repression of beta-globin promoter activity by nuclear ferritin.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. UNITED STATES 31 JUL 2001, (20010731), vol. 98, no. 16, ISSN 0027-8424, pages 9145 - 9150, XP002218772 [PX] 1,5,11,19 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.151147098
Examination   - PICARD ET AL, "Overexpression of the Ferritin H subunit in cultured erythroid cells changes the intracellular iron distribution", BLOOD, (19960301), vol. 87, no. 5, pages 2057 - 2064, XP002401266
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.